Cargando…

The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy

Hepatocellular carcinoma (HCC) is ranked as the sixth most common cancer around the world. With the emergence of the state-of-the-art modalities lately, such as liver transplantation, image-guided ablation, and chemoembolization, the death rate is still high due to high metastasis rate after therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Feiyu, Zhong, Zhangfeng, Tan, Hor-Yue, Wang, Ning, Feng, Yibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408113/ https://www.ncbi.nlm.nih.gov/pubmed/32610709 http://dx.doi.org/10.3390/cancers12071734

Ejemplares similares

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
por: Huang, Jihan, et al.
Publicado: (2020)

Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p
por: Chen, Feiyu, et al.
Publicado: (2020)

Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF‐1α‐independent VEGF expression and angiogenesis in hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2020)

Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer
por: Chen, Feiyu, et al.
Publicado: (2020)

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
por: Guo, Wei, et al.
Publicado: (2019)

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
por: Guo, Wei, et al.
Publicado: (2018)

Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth—A Small Molecule Inhibitor, Berberine
por: Guo, Wei, et al.
Publicado: (2020)

Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
por: Guo, Wei, et al.
Publicado: (2020)

New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma
por: Tan, Hor-Yue, et al.
Publicado: (2016)

Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring
por: Shaik, Mohammed Rifat, et al.
Publicado: (2023)

Surveillance for hepatocellular carcinoma: It is time to move forward
por: Kim, Bo Hyun, et al.
Publicado: (2022)

IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma
por: Tan, Hor-Yue, et al.
Publicado: (2016)

microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
por: Wang, Ning, et al.
Publicado: (2018)

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
por: Zhong, Zhangfeng, et al.
Publicado: (2022)

Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine
por: Chen, Feiyu, et al.
Publicado: (2022)

The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
por: Li, Sha, et al.
Publicado: (2020)

Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
por: Xu, Yu, et al.
Publicado: (2020)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology
por: Huang, Jihan, et al.
Publicado: (2017)

Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA
por: Thakral, Deepshi, et al.
Publicado: (2020)

Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
por: Wu, Junyu, et al.
Publicado: (2023)

The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
por: Jiang, Xue, et al.
Publicado: (2019)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde
por: Wang, Ning, et al.
Publicado: (2017)

Atg9b Deficiency Suppresses Autophagy and Potentiates Endoplasmic Reticulum Stress-Associated Hepatocyte Apoptosis in Hepatocarcinogenesis
por: Wang, Ning, et al.
Publicado: (2017)

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
por: Fujii, Yasutoshi, et al.
Publicado: (2021)

Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
por: Li, Rui-Yu, et al.
Publicado: (2020)

Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
por: Lu, Yuanjun, et al.
Publicado: (2022)

Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
por: Chiappini, Franck
Publicado: (2012)

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
por: Saffroy, R, et al.
Publicado: (1999)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Circulating tumor DNA moves further into the spotlight
por: Sausen, Mark, et al.
Publicado: (2014)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study
por: Hamaoka, Michinori, et al.
Publicado: (2019)

A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2023)

An Approach towards Motion-Tolerant PPG-Based Algorithm for Real-Time Heart Rate Monitoring of Moving Pigs
por: Youssef, Ali, et al.
Publicado: (2020)

Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases
por: Li, Sha, et al.
Publicado: (2016)

Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas
por: Konczalla, Leonie, et al.
Publicado: (2020)

The significance of exosomes in the development and treatment of hepatocellular carcinoma
por: Li, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hnm37sr2ned7ogjp7gtkg3tifc